Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
7.55
+0.06 (0.80%)
At close: Aug 22, 2025, 4:00 PM
7.78
+0.23 (3.05%)
After-hours: Aug 22, 2025, 7:35 PM EDT
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $919.42 million as of August 22, 2025. Its market cap has increased by 400.13% in one year.
Market Cap
919.42M
Enterprise Value
716.42M
1-Year Change
400.13%
Ranking
Category
Stock Price
$7.55
Market Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $919.42M, an increase of 981.80%. That is a compound annual growth rate of 45.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2025 | 912.11M | 147.73% |
| Dec 31, 2024 | 368.19M | 330.28% |
| Dec 29, 2023 | 85.57M | -26.01% |
| Dec 30, 2022 | 115.65M | 472.04% |
| Dec 31, 2021 | 20.22M | -54.55% |
| Dec 31, 2020 | 44.48M | -33.49% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 633.30B |
| Johnson & Johnson | 430.71B |
| AbbVie | 369.48B |
| UnitedHealth Group | 271.56B |
| AstraZeneca | 250.11B |
| Novartis AG | 246.48B |
| Novo Nordisk | 239.90B |
| Abbott Laboratories | 230.51B |